Slim pickings for two weight-loss drugs?

Many medications for weight loss have been proposed or are under development. The Federal Drug Administration has approved few drugs for long-term weight loss, and some are no longer marketed because of safety issues, researchers of a new study have reported. In 2012, though, the FDA approved two drugs for long-term weight loss, lorcaserin hydrochloride (Belviq; Eisai Inc) and phentermine/topiramate (Qsymia; Vivus Inc). But Dartmouth researchers question how safe these two drugs are based on the FDA approval after one-year trials?

Read more...